SCHEMBL28126408

SCHEMBL28126408

Cc1c(C(=O)O)ccc(CBr)c1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
TSHR P16473 1/20 0.35
HAAO P46952 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRA4 P48169 1/20 0.34
GABRE P78334 1/20 0.34
GABRA6 Q16445 1/20 0.34
GABRG1 Q8N1C3 1/20 0.34
GABRG3 Q99928 1/20 0.34
GABRQ Q9UN88 1/20 0.34
ALDH1A1 P00352 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27590576 0.86 FOLH1 (0.36) CYP1A2TSHRHAAOGABRPGABRD
SCHEMBL27417962 0.85 GABRP (0.41) CYP1A2TSHRHAAOGABRPGABRD
Nitrobenzene SCHEMBL28178563 0.84 TSHR (0.44) TSHRALDH1A1KMT2AALOX15
SCHEMBL28127936 0.83 METAP2 (0.40) CYP1A2TSHRHAAOGABRPGABRD
SCHEMBL27475387 0.82 LMNA (0.39) TSHRGABRA1GABRB2ALDH1A1AKR1C3
SCHEMBL27968107 0.81 CYP1A2 (0.37) CYP1A2TSHRHAAOGABRPGABRD
SCHEMBL27287111 0.81 GABRP (0.38) CYP1A2TSHRHAAOGABRPGABRD
SCHEMBL8921714 0.81 CYP1A2 (0.37) CYP1A2TSHRHAAOGABRPGABRD
SCHEMBL27535391 0.81 CYP1A2 (0.37) CYP1A2TSHRHAAOGABRPGABRD
SCHEMBL27536275 0.81 DCLRE1B (0.45) CYP1A2TSHRHAAOGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106687458-A Substituted oxopyridine derivatives 拜耳制药股份公司 2017-05-17 CN disclosed